METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS

The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma ("PTCL"), lymphoma is angioimmunoblastic T-cell lymphoma (AITL), acute myeloid leukemia (AML), or chronic myelomonocytic leukemia (CM...

Full description

Saved in:
Bibliographic Details
Main Author Gualberto, Antonio
Format Patent
LanguageEnglish
Published 12.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma ("PTCL"), lymphoma is angioimmunoblastic T-cell lymphoma (AITL), acute myeloid leukemia (AML), or chronic myelomonocytic leukemia (CMML), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics.
Bibliography:Application Number: US202017435276